Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.4215
H.R.4215: To amend title XVIII of the Social Security Act to ensure that providers of services receive adequate payments for the acquisition of hematopoietic stem cells under the Medicare program, and for other purposes.
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced Nov. 1, 2017
- Latest Major Action Nov. 1, 2017
Bill Sponsor
Bill Cosponsors
26 (15 Democrats, 11 Republicans)
Bill Version
- Introduced in House - Nov. 1, 2017
Bill Summary
This bill requires the Centers for Medicare & Medicaid Services to pay, to a provider that furnishes a hematopoietic stem cell transplant, an adjusted Medicare payment consistent with the Medicare payment methodology for kidney-acquisition costs outlined in regulation. Under the applicable regulation, kidney-acquisition costs are treated apart from the prospective payment rate for inpatient operating costs, and payment is adjusted to...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Nov. 1, 2017 |
Referred to the House Committee on Ways and Means.
|
Nov. 1, 2017 |
Introduced in the House by Erik Paulsen (R-Minn.) |